Daniel Kotlarz

Heisenberg Professorship, Precision medicine in pediatric inflammatory bowel disease

Dr von Haunersches Kinderspital Kinderklinik und Kinderpoliklinik der Ludwig Maximilian Universität München

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Daniel Kotlarz is a Heisenberg Professor at Dr von Haunersches Kinderspital Kinderklinik und Kinderpoliklinik der Ludwig Maximilian Universität München. He specializes in precision medicine for pediatric inflammatory bowel disease, focusing on genetic and immunological factors. His recent research includes studies on interleukin-10 receptor variants, the clinical features of inflammatory bowel diseases, and the impact of genetic mutations on disease presentation in children. His work contributes significantly to understanding the complexities of pediatric chronic inflammation and related genetic disorders.

Articles (7)

Year:

2023

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Elizabeth Spencer

Assistant Professor

Mount Sinai Hospital

UNITED STATES

View details

Dominik Aschenbrenner

University of Oxford

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Daniel Kotlarz

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Pathogenic Interleukin-10 Receptor Alpha Variants in Humans — Balancing Natural Selection and Clinical Implications

Clinical and Mutation Description of the First Iranian Cohort of Infantile Inflammatory Bowel Disease: The Iranian Primary Immunodeficiency Registry (IPIDR)

Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies.

Dysregulation of Cell Death in Human Chronic Inflammation

Prevalence and Clinical Features of Inflammatory Bowel Diseases Associated With Monogenic Variants, Identified by Whole-Exome Sequencing in 1000 Children at a Single Center

Drug Screen Identifies Leflunomide for Treatment of Inflammatory Bowel Disease Caused by TTC7A Deficiency

NOX1 Regulates Collective and Planktonic Cell Migration: Insights From Patients With Pediatric-Onset IBD and NOX1 Deficiency

Collaborators (2)

Elizabeth Spencer

Dominik Aschenbrenner

Make your next move.